-
Mashup Score: 2Anti-tumor effect by either FLASH or conventional dose rate irradiation involves equivalent immune responses. - 6 month(s) ago
: The capability of ultra-high dose rate FLASH radiotherapy (FLASH) to generate the FLASH effect has opened the possibility to enhance the therapeutic index of radiotherapy. The contribution of the immune response has frequently been hypothesized to account for a certain fraction of the anti-tumor efficacy and tumor kill of FLASH but has yet to be rigorously evaluated.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 50
In a phase III randomized trial, adding a radiation boost to tumor(s) visible on MRI improved prostate cancer (PCa) disease-free and metastasis-free survival without additional toxicity. Radiation oncologists’ ability to identify prostate tumors is critical to widely adopting intraprostatic tumor radiotherapy boost for patients. A diffusion MRI biomarker, called the Restriction Spectrum Imaging restriction score (RSIrs), has been shown to improve radiologists’ identification of clinically significant PCa.
Source: www.redjournal.orgCategories: General Medicine News, Onc News and JournalsTweet
Check out some of the last findings in FLASH research: The immune contribution of FLASH and CONV are equivalent in tumors, now live in the #RedJournal. #radonc https://t.co/2deBU94PvA https://t.co/5pl3BfkwdT